The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

BACKGROUND: Aztreonam lysine for inhalation (AZLI) is an inhaled antibiotic used to treat chronic Pseudomonas aeruginosa infection in CF. AZLI improves lung function and quality of life, and reduces exacerbations-improvements attributed to its antipseudomonal activity. Given the extremely high aztre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Microbiome
Main Authors: Heirali, Alya A., Workentine, Matthew L., Acosta, Nicole, Poonja, Ali, Storey, Douglas G., Somayaji, Ranjani, Rabin, Harvey R., Whelan, Fiona J., Surette, Michael G., Parkins, Michael D.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5420135/
https://ncbi.nlm.nih.gov/pubmed/28476135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40168-017-0265-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares